The post-hoc analysis can’t tease out what’s driving the long-term advantage, though some experts have possible explanations.

MADRID, Spain—Stopping oral anticoagulation (OAC) improves outcomes among patients who remain free from atrial arrhythmia ...

This highlights the need to prospectively study these types of tools before implementing them in routine care, researchers ...

MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) ...

Whether such screening reduces the risk of stroke and other hard clinical endpoints remains to be seen, say investigators.

What to make of the registry findings is debatable, but a mortality signal in PAD patients with claudication raised eyebrows.

Health workers going to patients’ houses and nurses prescribing medications were key aspects of the program’s success.

The data do, however, hint at the benefit of a more tailored approach focusing on groups with higher bleeding risks.

The single-center data, based on echocardiography, reinforce the need for cautious procedural planning in certain subsets.

The REFINE-ICD results highlight the need to find better ways to identify at-risk patients who might benefit, one expert says ...

Earlier, less-invasive treatment is at the core of the latest iteration of the joint European Society of Cardiology/European ...

It’s the first PCSK9 inhibitor to get the FDA’s approval for reducing MACE in patients without established cardiovascular ...